Scientific article

Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation

Published inAmerican Journal of Transplantation, vol. 19, no. 3, p. 844-854
Publication date2019

Live-attenuated vaccines are currently contraindicated in solid-organ transplant recipients. However, the risk of vaccine-preventable infections is lifelong, and can be particularly severe after transplantation. In this prospective interventional national cohort study, 44 pediatric liver transplant recipients with measles IgG antibodies <150 IU/L (below seroprotection threshold) received measles-mumps-rubella vaccine (MMR) at a median of 6.3 years posttransplantation (interquartile range, 4.0 to 10.9). A maximum of two additional doses were administered in nonresponders or when seroprotection was lost. Vaccine responses occurred in 98% (95% confidence interval [CI], 88-100) of patients. Seroprotection at 1-, 2-, and 3-year follow-up reached 62% (95% CI, 45-78), 86% (95% CI, 70-95), and 89% (95% CI, 67-99), respectively. All patients responded appropriately to the booster dose(s). Vaccinations were well tolerated and no serious adverse event attributable to vaccination was identified during the 8-week follow-up period (or later), using a multimodal approach including standardized telephone interviews, diarized side effect reporting, and monitoring of vaccinal virus shedding. We conclude that live attenuated MMR vaccine can be administered in liver transplant recipients fulfilling specific eligibility criteria (>1 year posttransplantation, low immunosuppression, lymphocyte count ≥0.75 G/L), inducing seroprotection in most subjects. (Clinicaltrials.gov number NCT01770119).

  • Clinical research/practice
  • Clinical trial
  • Infection and infectious agents—viral
  • Infectious
  • Disease
  • Liver transplantation/hepatology
  • Pediatrics
  • Vaccine
Citation (ISO format)
PITTET, Laure et al. Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation. In: American Journal of Transplantation, 2019, vol. 19, n° 3, p. 844–854. doi: 10.1111/ajt.15101
Main files (1)
Article (Published version)
ISSN of the journal1600-6135

Technical informations

Creation30.04.2019 11:17:00
First validation30.04.2019 11:17:00
Update time15.03.2023 16:25:55
Status update15.03.2023 16:25:54
Last indexation19.10.2023 10:30:20
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack